Results 161 to 170 of about 89,075 (280)

Systemic therapies for intrahepatic cholangiocarcinoma.

Journal of Hepatology, 2020
R. Kelley, J. Bridgewater, G. Gores, A. Zhu   +3 more
semanticscholar   +1 more source

Pathology of Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma [PDF]

Clinical Liver Disease, 2021
openaire   +2 more sources

A Case of Obstructive Jaundice due to Bile Duct Tumor Thrombus of Hepatocellular Carcinoma Diagnosed by Peroral Cholangioscopy

DEN Open, Volume 6, Issue 1, April 2026.
Abstract While hepatocellular carcinoma (HCC) often invades the portal or hepatic vein to form tumor thrombus, tumor thrombus in the bile duct is rare. In such cases, differentiation from intrahepatic cholangiocarcinoma is difficult, and the tumor often appears as a smooth, yellowish‐white, polypoid mass within the bile duct lumen.
Keisuke Kinoshita, Mizuki Endo, Tomoko Tokumaru, Tomoko Saito, Takuro Uchida, Masao Iwao, Mie Arakawa, Kazuhisa Okamoto, Masaaki Kodama, Kazunari Murakami   +9 more
wiley   +1 more source

Scheduled Inside Plastic Stent Exchange Prevents Cholangitis and Reduces Unplanned Hospitalization in Patients With Unresectable Malignant Hilar Biliary Obstruction

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives To prevent cholangitis in patients with unresectable malignant hilar biliary obstruction (MHBO), we recently implemented scheduled inside plastic stent (IS) exchange every 2–4 months. This study aimed to evaluate whether this strategy prevents cholangitis onset and reduces unplanned hospitalizations without increasing adverse events.
Joji Muramatsu, Kazuma Ishikawa, Norito Suzuki, Tomohiro Kubo, Makoto Yoshida, Ginji Omori, Ryo Ito, Shogo Miura, Kohichi Takada   +8 more
wiley   +1 more source

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance

Cell Death and Disease, 2021
Kitti Intuyod, Paula Saavedra-García, Stefania Zona, Chun-Fui Lai, Yannasittha Jiramongkol, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Shang Yao, Jay-Sze Yong, Sasanan Trakansuebkul, Sakda Waraasawapati, Vor Luvira, Sopit Wongkham, Somchai Pinlaor, Eric W.-F. Lam   +14 more
doaj   +1 more source

CT-derived Body Composition Radiomics to Predict Early Recurrence in Intrahepatic Cholangiocarcinoma. [PDF]

Radiol Imaging Cancer
Singh Y.
europepmc   +1 more source

Targeting FGFR inhibition in cholangiocarcinoma.

Cancer Treatment Reviews, 2021
L. Goyal, S. Kongpetch, V. Crolley, J. Bridgewater   +3 more
semanticscholar   +1 more source

A Clinical Scoring Model to Predict Post‐Endoscopic Retrograde Cholangiopancreatography Pancreatitis in Biliary Endoscopic Retrograde Cholangiopancreatography for Patients With Intact Papilla: A Large Multicenter Prospective Cohort Study

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives The risk of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) needs to be predicted in order to take adequate preventive measures in individual cases. The aim of this study was to develop a clinical prediction rule for PEP in biliary ERCP for patients with intact papilla.
Koichi Fujita, Shujiro Yazumi, Hisakazu Matsumoto, Masanori Asada, Hiroko Nebiki, Keiji Hanada, Kazuya Matsumoto, Toru Maruo, Mamoru Takenaka, Hideki Kamada, Chishio Noguchi, Hidefumi Nishikiori, Toshifumi Doi, Teru Kumagi, Takao Iemoto, Nobuaki Azemoto, Takashi Kawamura, Hirofumi Kawamoto, for the Bilio‐pancreatic Study Group of West Japan   +18 more
wiley   +1 more source

Acute Myocardial Infarction Due to Nonbacterial Thrombotic Endocarditis in Advanced Intrahepatic Cholangiocarcinoma: A Case Report. [PDF]

Am J Case Rep
Ebina G, Tanaka S, Asonuma S, Suzuki H, Tomioka T.   +4 more
europepmc   +1 more source

Liver resection and transplantation for intrahepatic cholangiocarcinoma.

Journal of Hepatology, 2020
V. Mazzaferro, Andre Gorgen, S. Roayaie, M. Droz dit Busset, G. Sapisochin   +4 more
semanticscholar   +1 more source